#1 Clinical Trials Search in Europe

Diltiazem

Diltiazem, a calcium channel blocker, has been the subject of numerous clinical trials investigating its efficacy in treating various medical conditions. This article explores the use of diltiazem in clinical studies, focusing on its applications in cardiovascular disorders, anal fissures, and drug interactions. We’ll examine how diltiazem is being tested in different formulations and dosages to address specific health concerns and improve patient outcomes.

Table of Contents

What is Diltiazem?

Diltiazem is a medication that belongs to a class of drugs called calcium channel blockers. It’s known by several brand names, including Cardizem®, Cartia XT®, and Matzim LA®[1]. This medication is primarily used to treat high blood pressure (hypertension) and certain types of chest pain (angina).

Uses of Diltiazem

Diltiazem is prescribed for several medical conditions:

  • Hypertension (High Blood Pressure): Diltiazem helps lower blood pressure by relaxing blood vessels[2].
  • Angina (Chest Pain): It can help prevent and treat chest pain caused by reduced blood flow to the heart[2].
  • Atrial Fibrillation and Flutter: Diltiazem is used to control rapid heart rates in these conditions[3].
  • Coronary Artery Spasm: It may help prevent spasms in the coronary arteries[4].
  • Preeclampsia: Some studies have explored its use in managing blood pressure in severe preeclampsia during the postpartum period[5].

How Diltiazem Works

Diltiazem works by blocking calcium channels in the heart and blood vessels. This action has several effects:

  • It relaxes and widens blood vessels, making it easier for blood to flow.
  • It reduces the workload on the heart.
  • It slows down electrical conduction in the heart, which can help control rapid heart rates.

Interestingly, diltiazem is about 1000 times less potent than another calcium channel blocker called nifedipine, but it produces a more selective dilation of arteries[5].

Administration and Dosage

Diltiazem comes in several forms:

  • Oral tablets: These can be immediate-release or extended-release formulations.
  • Intravenous (IV) injection: Used in hospital settings for rapid control of heart rate or blood pressure.

The dosage varies depending on the condition being treated and the individual patient. For example:

  • For high blood pressure, a common starting dose might be 30mg taken orally three or four times a day[6].
  • For atrial fibrillation, an IV dose might start at 0.25 mg/kg, followed by a continuous infusion[3].

Always follow your doctor’s instructions regarding dosage and administration.

Potential Side Effects

Like all medications, diltiazem can cause side effects. Common side effects may include:

  • Headache
  • Dizziness
  • Slow heart rate
  • Constipation
  • Swelling in the legs or ankles

More serious side effects, though rare, can include severe low blood pressure, heart rhythm problems, or allergic reactions. If you experience any severe or persistent side effects, contact your healthcare provider immediately[1].

Drug Interactions

Diltiazem can interact with other medications. For example:

  • It may increase the blood levels of certain statins (cholesterol-lowering drugs)[7].
  • It can interact with other blood pressure medications, potentially causing excessive lowering of blood pressure.
  • It may interact with certain heart medications, like beta-blockers.

Always inform your healthcare provider about all medications, supplements, and herbal products you’re taking.

Ongoing Research

Researchers continue to study diltiazem for various conditions:

  • COVID-19: A study is evaluating diltiazem’s potential to reduce viral load in patients hospitalized with COVID-19 pneumonia[6].
  • Jervell and Lange-Nielsen Syndrome: Researchers are investigating diltiazem’s effect on the QT interval in this rare heart rhythm disorder[8].
  • Anal Fissures: Studies are exploring the use of topical diltiazem for this condition[9].

These ongoing studies may lead to new uses for diltiazem in the future.

Aspect Details
Formulations Studied Oral tablets, intravenous infusions, topical creams
Medical Conditions Atrial fibrillation, anal fissures, coronary artery spasm, hypertension, preeclampsia
Key Outcomes Measured Blood pressure control, heart rate regulation, pain reduction, pharmacokinetic parameters
Safety Assessments Adverse events, clinical laboratory results, vital signs, local sensitivity reactions
Drug Interactions Studies with pitavastatin and other cardiovascular medications
Special Populations Pregnant women, patients with genetic disorders (e.g., Jervell and Lange-Nielsen Syndrome)
Comparative Studies Diltiazem vs. other medications (e.g., nifedipine, nebivolol)

FAQ

  • What is diltiazem and how does it work? Diltiazem is a calcium channel blocker that works by relaxing blood vessels and slowing heart rate. It's primarily used to treat high blood pressure, chest pain (angina), and certain heart rhythm disorders.
  • In which medical conditions is diltiazem being studied? Clinical trials are exploring diltiazem's effectiveness in various conditions, including atrial fibrillation, anal fissures, coronary artery spasm, diabetic nephropathy, and as part of combination therapies for hypertension.
  • How is diltiazem administered in clinical trials? Diltiazem is being tested in various forms, including oral tablets, intravenous infusions, and topical creams. The method of administration depends on the specific condition being studied and the trial's objectives.
  • Are there any potential drug interactions with diltiazem being investigated? Yes, some trials are specifically looking at drug interactions between diltiazem and other medications, such as pitavastatin. These studies aim to understand how diltiazem may affect the pharmacokinetics of other drugs.
  • What are some common outcomes measured in diltiazem clinical trials? Common outcomes include changes in blood pressure, heart rate control, reduction in symptoms (e.g., pain in anal fissures), pharmacokinetic parameters, and safety assessments such as adverse events and laboratory results.

Ongoing Clinical Trials on Diltiazem

  • Study on the Effects of Warfarin, Lysine Aspirin, and Clopidogrel in Patients with Myocardial Infarction and Non-Obstructive Coronary Arteries (MINOCA)

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

Glossary

  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Atrial Fibrillation: An irregular and often rapid heart rate that can increase the risk of strokes, heart failure, and other heart-related complications.
  • Anal Fissure: A small tear in the thin, moist tissue that lines the anus, often causing pain during bowel movements.
  • Coronary Artery Spasm: A temporary tightening of the muscles in the wall of one of the arteries that sends blood to the heart, which can cause chest pain and lead to a heart attack.
  • Preeclampsia: A pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys.
  • Jervell and Lange-Nielsen Syndrome: A rare genetic disorder characterized by severe hearing loss from birth and a disruption of the heart's normal rhythm.
  • QT Interval: A measurement on an electrocardiogram that represents the time it takes for the heart's electrical system to fire an impulse and then recharge.
  • Proteinuria: The presence of excess proteins in the urine, which can be a sign of kidney damage.
  • Glomerular Filtration Rate (GFR): A test used to check how well the kidneys are working by estimating how much blood passes through the glomeruli each minute.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT06692647
  2. https://clinicaltrials.gov/study/NCT00713011
  3. https://clinicaltrials.gov/study/NCT03472495
  4. https://clinicaltrials.gov/study/NCT03930433
  5. https://clinicaltrials.gov/study/NCT04222855
  6. https://clinicaltrials.gov/study/NCT05563168
  7. https://clinicaltrials.gov/study/NCT01422382
  8. https://clinicaltrials.gov/study/NCT06534671
  9. https://clinicaltrials.gov/study/NCT01816191